AUDIOCONFERENCE ON TAPE OR CD
Sponsored by MSL Compliance Training Workshops
presented on April 19, 2007
Do your medical science liaisons' (MSL) activities meet compliance? Are you sure?
The only way to be certain your MSLs conduct themselves in accordance with the law is to audit their activities and establish an ongoing program that monitors them. Developing and implementing a program is an investment that far outweighs the risk to compliance—as well as the bottom line—that shouldn't be ignored.
Listen to ePharmaceuticals for Medical Liaisons: Best Practices to Audit and Monitor for Compliance. Learn best practices to audit and monitor your MSLs, as well as legal commentary and considerations to help ensure their approaches and activities will withstand legal scrutiny.
You'll hear what your peers are doing to address concerns about MSL compliance, and walk away from the program with detailed advice, strategies, and tactics you can put to work right away to minimize your organization's risk.
TAKE A LOOK AT OUR AGENDA
Introduction
- Auditor perspective
- Industry perspective on MSLs
I. Legal Considerations: What has happened, what does it mean?
- Updates on new investigations and the nature of investigations
- Common, note-worthy trends in investigations
- How to define role of MSL in policies/procedures/auditing/monitoring for compliance
- Government guidelines for MSLs
II. Strategies, Tools, and Tactics for Auditing and Monitoring
Best practices and recommendations: Interactive roundtable discussion
- How to audit MSLs
- How many audits to do in a year
- Tactics/tools
- How to select MSLs for audit
- How to respond to the findings
- What to monitor
- Frequency of monitoring checklist/grid
- How often to monitor
- How often to monitor/audit (CIA vs. non CIA company)
III. How to integrate the program across departments (i.e. with legal, compliance, medical affairs, and the field team)
Q&A
FEATURED SPEAKERS
Bruce Armon, Esq., is a partner in Saul Ewing's Business Department in its Philadelphia and chair of the Life Science's regulatory privacy, and healthcare contracting practice group. He is a faculty member in ePharmaceutical’s custom MSL compliance workshops for pharmaceutical and biotech companies.
Robert G. Sikora, M.S., Pharmacy Administration, is the retired vice president of clinical education at Pfizer, Inc., where he oversaw the clinical field force and worked closely with company attorneys to develop compliance policies and procedures for Pfizer's Clinical Education Consultants. He spent more than 20 years as an Army pharmacist, director of pharmacies, and clinical educator.
A. Monica Jonhart (moderator) is the director of compliance, auditing and U.S. healthcare law compliance at Bristol-Myers Squibb. She is based in Trenton, NJ.
Bryan Cote (moderator) is an executive editor at HCPro, Inc.
WHO SHOULD LISTEN?
We encourage the following departments from pharmaceutical and biotech companies to attend:
- Medical Science Liaison team (director level and field team)
- Medical Affairs
- Compliance and Legal
Site licenses for entire MSL or medical affairs divisions are available. Contact Maureen Croce at ePharmaceuticals for details.
PROGRAM MATERIALS
Program materials are provided with PDF links. Purchase a tape or CD of the program to listen and learn at your convenience.
Save money when you purchase multiple copies! Ask your customer service representative about money-saving
discounts and bulk orders. Call toll free 800-650-6787 or e-mail
customerservice@hcpro.com.
